Prostate cancer pill launches in UK
In the UK, there has been a recent launch of a life-prolonging prostate cancer pill but NHS patients have not got an access to it yet.
Men with advanced prostate cancer have been benefitted with Abiraterone acetate, marketed under the trade name Zytiga as their lives have been extended.
About 14 days ago, it received a European Union licence, and this has made it a legal medicine in the UK, but actually only patients have been able to access it yet.
Generation of testosterone in all tissues, including cancer tumors are blocked by the drug. Prostate cancer grows and spreads with the male sex hormone.
There was a phase III trial conducted on about 2,000 men who were in the advanced stages of cancer. There was an extension in the lives of men who took the drug by 15.8 months on average than men who took a placebo.
British researchers at the Institute of Cancer Research (ICR) and the Royal Marsden Hospital have developed Abiraterone.
Professor Alan Ashworth, chief executive of the ICR in London, said, “This drug will make a significant impact on the treatment of men suffering advanced prostate cancer.”
New Zealand News
- German automaker Volkswagen invests $620 million in Northvolt to secure EV battery supply
- Top places to see in Singapore
- Xpeng enjoys 483% year-over-year jump in May 2021 deliveries; thanks to robust sale of P7
- Tesla offering new discounts & perks in China amid negative press
- Electric Vehicle Council slams Victoria Government for proposed punitive mileage tax on electric cars
- Garelli rolls out new electric scooter Ciclone E4 with more power
- Stellantis reportedly in talks with Rome to build gigafactory in Italy
- Tesla pockets roughly $101 million in profit from sale of some of its bitcoins
- Norway’s ICE car sales decline as buyers making shift to EVs
- Pursang launches Retro-inspired E-Track Motorcycle for Euro 14,449 in Netherlands